Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Neurochemistry International|May 28, 2010
Autoradiographic localization of 5-HT(3) receptor ligand binding in the cat brainstemD J Reynolds, R A Leslie, D G Grahame-Smith, et al.
British Journal of Clinical Pharmacology|August 1, 1979
The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapyA R Ford, J K Aronson, D G Grahame-Smith, et al.
British Journal of Clinical Pharmacology|August 1, 1979
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillationA R Ford, J K Aronson, D G Grahame-Smith, et al.
British Journal of Pharmacology|February 1, 1976
Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugsJ P Evans, D G Grahame-Smith, A R Green, et al.
British Journal of Clinical Pharmacology|February 1, 1975
Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet propertiesD J Boullin, D G Grahame-Smith, R P Grimes, et al.
British Journal of Pharmacology|June 1, 1982
beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responsesP J Cowen, D G Grahame-Smith, A R Green, et al.
Lancet (London, England)|August 21, 1982
Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responsesD W Costain, P J Cowen, M G Gelder, et al.
Brain Research|November 29, 1991
Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694)D J Reynolds, N A Barber, D G Grahame-Smith, et al.
Neuropharmacology|March 1, 1996
Chronic electroconvulsive shock enhances 5-HT2 receptor-mediated head shakes but not brain C-fos inductionJ M Moorman, D G Grahame-Smith, S E Smith, et al.
British Journal of Clinical Pharmacology|June 1, 1985
Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmissionP J Cowen, A R Green, D G Grahame-Smith, et al.
Pageof 17